Here is what we stand to lose if we let private insurers write Canada’s pharmacare plan
Canada stands at a crossroads on pharmacare. Will we build a program that guarantees medication for all, or one that protects the profits of private insurers? Nearly a year after Parliament passed Bill C-64, Canada’s long-promised pharmacare plan is back in the spotlight — and at risk of being watered down.